BEIJING, April 21, 2025 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the “Company” or “HAO”), an online marketing solution provider headquartered in Beijing, China, announced that Beijing Haoxi Digital Technology Co., Ltd. (“Haoxi Beijing”), a wholly-owned subsidiary of the Company, has launched its customized livestreaming agency strategy and is progressing partnership discussions on personalized livestreaming agency services with several long-term clients of medical aesthetics, marking a new strat ...

BEIJING, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the “Company” or “HAO”), an online marketing solution provider headquartered in Beijing, China, today announced that it received a formal notification from the Nasdaq Stock Market LLC (“Nasdaq”) that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires the Company’s Class A ordinary shares, par value US$0.0025 each (the “Ordinary Shares”) to maintain a minimum bid price of $1.00 per share. The Nasd ...

Core Viewpoint - Haoxi Health Technology Limited has announced a reverse share split of its ordinary shares at a ratio of 1-for-25, which was approved by shareholders and will take effect on January 27, 2025 [1][2]. Group 1: Reverse Share Split Details - The reverse share split will combine every 25 shares of Class A and Class B ordinary shares into one share, reducing the total outstanding Class A shares from approximately 53.29 million to about 2.13 million and Class B shares from approximately 17.27 million to about 0.69 million [2]. - The company's Articles and Memorandum of Association have been amended to proportionately reduce the number of authorized shares and adjust the par value of the post-reverse share split ordinary shares to $0.0025 per share [3]. - No fractional shares will be issued; instead, entitlements to fractional shares will be rounded up to the nearest whole share [3]. Group 2: Market Impact and Expectations - Following the reverse share split, the Class A ordinary shares are expected to trade at approximately twenty-five times the price per share prior to the split, although the company cannot guarantee that this price will be maintained [4]. - The new CUSIP number for the Class A ordinary shares will be G4290F118, and trading will commence on an adjusted basis on the Nasdaq Capital Market [1][2]. Group 3: Company Overview - Haoxi Health Technology Limited is an online marketing solution provider based in Beijing, China, focusing on the healthcare industry [6]. - The company's growth is driven by the rise of news feed ads and the rapid development of the healthcare sector, offering one-stop online marketing solutions, particularly in online short video marketing [6].

BEIJING, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the “Company” or “HAO”), an online marketing solution provider headquartered in Beijing, China, today announced the Company’s wholly owned subsidiary Beijing Haoxi Digital Technology Co., Ltd. (“Beijing Haoxi”) was awarded a Recharge Service Framework Contract (the “Contract”) to provide comprehensive digital advertising services with a budget of RMB30 million for Tengyuan Media Advertising Co., Ltd. (“Tengyuan") and its clients. Pu ...

BEIJING, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the "Company" or "HAO"), an online marketing solution provider headquartered in Beijing, China, today reported its financial results for the fiscal year ended June 30, 2024. Financial Highlights for Fiscal 2024 Net revenue for the fiscal year ended June 30, 2024 grew by 72% to $48.52 million, up from $28.23 million in 2023. Gross profit increased by 33% to $2.75 million for the fiscal year ended June 30, 2024 from $2.06 million in t ...

BEIJING, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the “Company” or “HAO”), an online marketing solution provider headquartered in Beijing, China, today announced preliminary unaudited financial results for the fiscal year ended June 30, 2024 (“FY24”). HAO projects revenue growth during FY24, which it attributes to the Company’s strategic development in online advertising solutions, particularly through short video formats and news feed ads. The Company’s proprietary data analysis s ...

BEIJING, May 31, 2024 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the "Company" or "HAO"), an online marketing solution provider headquartered in Beijing, China, today reported its unaudited financial results for the six months ended December 31, 2023. Financial Highlights for the Six Months Ended December 31, 2023 Total revenue for the six months ended December 31, 2023 was US$23.50 million, increased by US$14.34 million, or 157%, from US$9.16 million for the same period in 2022.Gross profit for t ...

BEIJING, May 03, 2024 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the "Company" or "HAO"), an online marketing solution provider headquartered in Beijing, China, today announced that Beijing Haoxi Digital Technology Co., Ltd. ("Haoxi Beijing"), a wholly-owned subsidiary of the Company, entered into a Framework Contract for Cooperation on Information Placement on Media Platforms (the "Framework Contract") on April 28, 2024 with Wuhan Yiya Simei Dental Clinic Co., Ltd. ("Yiya Dental"), a regional den ...

Loading...Loading...The most oversold stocks in the communication services sector presents an opportunity to buy into undervalued companies.The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.Here’s the latest ...

BEIJING, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the "Company" or "HAO"), an online marketing solution provider headquartered in Beijing, China, today announced the closing of its initial public offering (the "Offering") of 2,400,000 Class A ordinary shares (the "Ordinary Shares") at an initial public offering price of $4.00 per share for total gross proceeds of $9,600,000, before deducting underwriting discounts and other offering expenses. The Offering closed on January 30, 2024 ...